Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties—Brief Report
Sign Up to like & getrecommendations! Published in 2017 at "Arteriosclerosis, Thrombosis, and Vascular Biology"
DOI: 10.1161/atvbaha.117.309523
Abstract: Objective— Apolipoprotein A-I (apoA-I) mimetic peptides have antiatherogenic properties of high-density lipoprotein in vitro and have been shown to inhibit atherosclerosis in vivo. It is unclear, however, if each in vitro antiatherogenic property of these… read more here.
Keywords: mimetic peptides; discordance; vitro vivo; vivo ... See more keywords
Abstract WP148: ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type 2 Diabetic Mice
Sign Up to like & getrecommendations! Published in 2019 at "Stroke"
DOI: 10.1161/str.50.suppl_1.wp148
Abstract: Diabetes mellitus leads to a higher risk of ischemic stroke and worse functional outcome compared to the general population. We investigate whether L-4F, an economical apolipoprotein A-I mimetic pe... read more here.
Keywords: reduces vascular; abstract wp148; peptide reduces; mimetic peptide ... See more keywords